Efficacy of Surgical Measures in Preventing Port-site Recurrences in a Porcine Model
Overview
General Surgery
Radiology
Affiliations
Background: Port-site recurrences are serious complications of laparoscopy performed for cancer. Incidences reported in the literature vary between 0% and 21%, suggesting an influence of the surgeon.
Methods: The aim of this experimental, prospective, randomized, single-blind study was to investigate the influence that the quality surgery has on the incidence of port-site recurrences. After a 12-mmHg carbon dioxide (CO2) pneumoperitoneum was created, 10(7) human HeLa cell were injected into the peritoneal cavity of 18 pigs, creating a xenogeneic tumor. Laparoscopic sigmoid resections then were performed using four trocars and a transanal double-stapling technique. The following protective measures were applied in nine animals: trocar fixation, prevention of gas leaks, rinsing of instruments with povidone-iodine, minilaparotomy protection, rinsing of trocars before removal, peritoneal closure, and rinsing of all wounds with povidoneiodine. Surgeons and type of procedures were randomized. After 4 weeks, the animals were killed and all portsites excised. Blinded immunohistologic analysis with antihuman pancytokeratin antibody was performed.
Results: Tumor recurrence was present in 23 of 36 port sites (63.8%) in the control group, but only in 5 of 36 port sites (13.8%) in the group that received protective measures (p = 0.002; Fisher's exact test). No peritoneal carcinosis nor anastomotic recurrences were observed.
Conclusion: These results strongly suggest that the quality of surgical technique has an influence on the incidence of port-site recurrences. From now on, we propose to use these protective measures routinely in cancer laparoscopy.
Starke O, Wimberger P, Klotz D Arch Gynecol Obstet. 2024; .
PMID: 39680144 DOI: 10.1007/s00404-024-07832-4.
Isolated Port Site Metastases in Carcinoma Gallbladder: Does it Represent Better Prognosis?.
Chauhan A, Ganguly M, Sharma A Indian J Surg Oncol. 2022; 8(3):258-262.
PMID: 36118397 PMC: 9478060. DOI: 10.1007/s13193-016-0553-x.
Fusegi A, Kanao H, Ishizuka N, Nomura H, Tanaka Y, Omi M Cancers (Basel). 2021; 13(23).
PMID: 34885205 PMC: 8657300. DOI: 10.3390/cancers13236097.
Watrowski R, Kostov S, Alkatout I Wideochir Inne Tech Maloinwazyjne. 2021; 16(3):501-525.
PMID: 34691301 PMC: 8512506. DOI: 10.5114/wiitm.2021.108800.
Huang L, Li H, Chen J, Jiang J, Zhang W, Liu T Radiol Case Rep. 2021; 16(7):1785-1789.
PMID: 34025887 PMC: 8121625. DOI: 10.1016/j.radcr.2021.04.009.